glp 1 psychiatry Prospects of GLP-1 Therapies for Addiction and Mental Health Comorbidities-Quo Vadis?: A Review Insights into a possible role

Sources: All data and statements above are based on current industry news, company releases, and expert analyses

Differences in clinical efficacy have been observed in headtohead comparisons between GLP1RAs in randomised controlled trials

Consider setting a benchmark like a 5% increase above your goal weight as a signal to check in with your healthcare provider for adjustments

This may indicate protein aggregation or bacterial contamination

We can and should discuss risks, side effects, cost, and appropriateness, but the concept of ongoing therapy is not inherently negative

doi: 10.2337/dc22-1148 [DOI] [PubMed] [Google Scholar] 26